Abstract 4656: Targeting Sp1 and survivin for potential ovarian cancer therapy: Comparative assessment of anti-cancer NSAID tolfenamic acid and cisplatin
Abstract:Introduction: Expression of specificity protein 1 (Sp1) transcription factor is negatively associated with survival in some cancer patients. Survivin, a member of Inhibitor of Apoptosis Protein family, causes resistance to chemo- and radiation therapy. Tolfenamic acid (TA), a NSAID, targets Sp1 and inhibits survivin expression in some cancer models. Our aims were to examine the expression of Sp1 and survivin in ovarian cancer (OC) specimens and compare the in vitro anticancer response of cisplatin and TA alone… Show more
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.